renal1 Flashcards
(360 cards)
Nephron
the nephron consists of blood supply and an epithelial tube, known as the tubule. The blood supply is remarkable, since it consists of two capillary beds in series; these are known as the glomerular and peritubular capillaries, respectively.
Glomerular Filtration
The first thing the nephron does to is filter the plasma into the initial part of the tubule. This process of filtration allows the free passage of water and solutes into the tubule, but retains larger colloids (i.e. proteins, lipid aggregates, etc.) and circulating blood cells in the blood.
Tubular Reabsorption
Once in the tubule, the kidney can recapture the filtered components that it wishes to regulate by a process generically known as reabsorption, which involves the transport of substances across the epithelia cell layer, and it involves highly selective transporters. Thus as the plasma filtrate flows through the tubule, the kidney can selectively regulate the rate of reabsorption of individual ECF components; these rates of reabsorption are constantly varied so that just enough ECF components are returned to the circulating plasma to achieve ECF constancy.
Excretion
Regulated substances in excess of those required to maintain ECF balance simply pass through the tubule and are excreted as part of the urinary output.
Regulation by tubular secretion
The forgoing description strictly applies to the two most abundant components of the ECF, water and sodium. However, other substances undergo a regulated process of secretion as part of their tubular handling to achieve ECF balance. Secretion is an epithelial transport process that involves the movement of substances from the blood or blood side of the tubule into the tubular lumen. It also often involves specific molecular transporters (channels and/or pumps). It’s also useful to mention that some substances can undergo both reabsorption and secretion within the tubule. As we shall see, the regulation of potassium (K+) involves just such a situation.
Non-ECF functions of the renal system
The kidneys perform a number of other functions not directly related to their role in ECF homeostasis. For example, the kidneys produce erythropoetin (EPO) from its precursor synthesized in the liver. Thus anemia has to be considered as a potential problem in the management of renal failure cases. In addition, the kidneys can contribute to gluconeogenesis, or the production of glucose from other metabolites in the situation of fasting or starvation.
The renin-angiotensin axis
However, the kidneys do play a hormonal role in the regulation of blood pressure by regulating the circulating levels of the potent vasopressor hormone angiotensin.
The Renin-Angiotensin axis
In this pathway, the primary regulatory event occurs when a decrease in blood pressure is sensed by baroreceptors, causing the kidneys to increase their secretion of the renal enzyme renin. The purpose of this enzyme is to cleave the 13 amino acid peptide prohormone angiotensingen to the10 amino acid angiotensin I (AgI), which is biologically inactive. However AgI circulates to the lungs, where it is cleaved by converting enzyme into the active form, angiotensin II (AgII). This hormone then circulates, causing arteriolar smooth muscle to constrict; the increased peripheral resistance thus causes a rise in blood pressure (MAP) back towards normal. The main thing to remember here is that the level of renin is rate-limiting for the production of AgII and thus determines the status of the axis. It’s useful to note that a number of antihypertensive agents are directed at this system, particularly the angiotensin converting enzyme (A.C.E.) inhibitors and angiotensin receptor antagonists.
Structure of the filtration apparatus
Filtration takes place across the capillary loops into Bowman’s capsule of the tubule; here the filtrate starts its journey through the tubule where it is processed into urine. The arterioles on either side of the glomerular capillary bed serve as valves that can control both the flow of plasma (and blood) through the filtration apparatus (and kidney) while regulating the glomerular filtration rate. Finally, the granular cells, a specialized subset of smooth muscle cells of the afferent arteriole, secrete renin, the enzyme that controls angiotensin II production. These cells are part of the juxtaglomerular apparatus (JGA).
Filtration properties of the glomerulus
Here the concentration of a substance in the filtrate formed in Bowman’s capsule relative to its concentration in the plasma, i.e. its filterability, is plotted as a function of the solute’s molecular size. Obviously for a freely filtered substance this value is 1, and for a totally excluded (nonfiltered) substance this number is zero. This molecular sieving process is also called “ultrafiltration”. Note that the dependence of filterability on molecular size is not especially sharp. Thus solutes up to several thousand daltons in size pass freely though the filter and even molecules up to 50,000 daltons have some measurable filterability. However, at around 60,000 daltons, substances do not pass through the filter, thus this value is referred to as the “molecular size cut-off” of the filter. This cut-off value is not accidental, however, since it is just lower than the size of the serum albumins (67,000 daltons). Nonetheless, significant amounts of smaller proteins do get through this filter (about 2 grams per day); these are reabsorbed and catabolized to their constituent amino acids by the tubular epithelial cells.
glomerular capillary endothelium.
The flow of the filtrate first passes through the glomerular capillary endothelium. Note that this endothelium lacks the usual slit membranes, thus it is known as a “fenestrated” epithelium. On a molecular scale, these holes are large, and they do not present much resistance to the movement of the plasma through them; hence they contribute little to the ultrafiltration properties of the glomerulus, except to exclude circulating red blood cells from entering the other layers.
podocytes
On the other side of the filter is a sheet of tubular epithelial cells known as podocytes. Instead of the usual cuboidal/columnar structure of typical epithelial cells, these have rounded cell bodies from which numerous “feet” (pedicels) are projected toward the endothelial cell layer. Feet from adjacent podocytes intimately intertwine; further there appear to be slit membranes that connect the feet. Thus it appears that the podocyte layer has the ability to function as a molecular sieve with the properties. Evidence for this view comes from human genetic diseases in which proteins that form the podocyte feet slits are defective and slits do not form; in these patients the glomerulus is very “leaky” and passes large proteins, suggesting that the slits themselves are molecular sieves.
the basal lamina
However, it also appears that the podocytes help create and support an equally important filtration barrier, the basal lamina. This structure is a thick basement membrane that is secreted by both the endothelial and epithelial cells into the space between them. It is composed of mucoproteins, which are large complexes of acidic sugars attached to protein cores. Similar to the well known nasal mucous (“snot”), on a molecular level this substance appears as a tightly woven mesh-work with holes of the correct dimensions that account for the filtration properties of the glomerulus. Further, the negatively charged basal lamina accounts for the observations that near the molecular size cut-off, highly positively charged macromolecules filter much better than would be predicted, whereas highly negatively charged macromolecules have a much lower than expected filterability. Also, as you will hear in other lectures in this series, a number of pathological conditions selectively affect the integrity of the basal lamina; this invariably results in deleterious changes to GFR. In any case, it seems most likely that both the podocyte feet slit membranes and the basal lamina contribute to the molecular sieving properties in the glomerulus.
Derivation of the Starling equation for filtration
Here we consider the GFR as a bulk flow of fluid across the glomerulus. Normally this flow extracts about 20% of the plasma as it flows along the glomerular capillaries, hence we say that the “normal filtration faction is 0.2”. How does so much fluid get filtered into the tubule? First, we consider that the GFR is just a special example of a transmural flow, i.e. a flow across a resistive boundary. The magnitude of such flows is simply given by the pressure difference across the boundary divided by the hydrodynamic resistance to flow of the boundary. For our case of GFR: GFR =deltaP/R where ΔP is the pressure across the filtration layers, and R is the resistance to flow. Let’s consider that R does not normally vary, hence we can simply give it a constant value “K”, and GFR = KDP
what are the pressures within the glomerulus that drive and resist filtration?
As for any capillary bed, filtration out of the capillary is driven by the value of the blood pressure where filtration occurs, i.e. for GFR the hydrostatic pressure within the glomerular capillary, Pgc. This is the only significant driving force for filtration. However, there are two significant forces that oppose glomerular filtration. The first results from the fact that the filtrate must flow in the narrow confines of the tubule. This results in a “backpressure” at Bowman’s capsule, which we denote by Pt. The second force is less obvious, but as you will see is strong indeed; it’s a net osmotic force that by itself would cause fluid to flow in the reverse direction to the GFR, hence the net osmotic force across the filtration apparatus is an opposing, negative force relative to glomerular capillary pressure.
How does the osmotic force arise?
It isn’t due to the normal tonicity of the plasma associated with dissolved ions and small solutes, since these filter freely across the glomerulus, and thus osmolarity due to freely filterable substances is the same on both sides of the glomerulus. Instead, on the blood side, the large dissolved proteins in the plasma (i.e. serum albumin, immunoglobulins) do not filter, hence as water is extracted from the plasma by filtration, the protein concentration rises, resulting in a net negative osmotic pressure that opposes filtration. We call this pressure the colloid osmotic pressure or COP. Sometimes this pressure is called the oncotic pressure. It is symbolized as πgc.
Net Filtration Pressure or NFP
we can now write the equation for GFR as: GFR=K(Pgc –Pt-piegc. The sum of the forces (Pgc-Pt- πgc) is called the Net Filtration Pressure or NFP. You will also recognize them as the “Starling forces” that describe glomerular capillary filtration.
Actual magnitudes of the forces and the NFP
Pgc=46mm, Pt=10mm, PIEgc=30mm. NFP=6mm
The potential role of changes in filtration area “A” in GFR regulation
The glomerular capillaries are covered by the so-called mesangial cells. It is thought that the mesangial cells can contract, and in doing so can decrease the filtration area, hence GFR. Thus it is possible that GFR to some unknown degree might be regulated or affected by the action of the mesangial cells. However, this principle of GFR regulation has not been fully established. However, an area where changes in filtration area, or indeed specific conductivity ρ are clearly important is in diseases that attack or affect the glomerular apparatus.
GFR is regulated to be relatively constant in normal physiology.
At this point we should discuss whether changes in GFR can be part of the overall regulatory picture for ECF substances under normal circumstances. For example, suppose a person drank a large excess of water; wouldn’t it make sense to simply increase the GFR while holding water reabsorption constant? This would certainly increase urinary excretion of water. The problem with this approach lies in the fact that the filtration process is nonspecific. Thus when one increases GFR with the aim of putting more water in the tubule, the other regulated solutes are also increasingly filtered; hence to stay in balance for all other regulated substances, one would have to increase the reabsorption (or decrease the secretion) for all of these other ECF components. Naturally this would result in a highly complex and energetically costly way of doing business. Instead, it appears that the renal system tries very hard to keep the GFR constant and then varies the rates of tubular handling of each regulated substance as necessary. For the example above, what happens is that GFR stays relatively unchanged but the rate of water reabsorption is decreased, resulting in the required increased urine output to stay in water balance.
The necessity for Pgc regulation
Note that under normal circumstances that Pgc is about half of the MAP found in major arteries. Naturally all capillary blood pressures are fairly low compared with MAP since the blood must flow some distance from the major arteries through ever narrowing blood vessels before reaching the capillary beds. Changes to MAP do not cause proportionate changes in glomerular capillary pressure. Instead, Pgc is very tightly regulated by the process of autoregulation.
GFR constancy
is maintained under normal conditions by glomerular capillary autoregulation. The phenomenon of autoregulation maintains blood flow in capillary beds very constantly in the face of a wide range of changes in arterial blood pressure (MAP). This is done via a myogenic mechanism, i.e. when MAP changes smooth muscle cells of the arteriole very precisely constrict or dilate in order to keep the downstream capillary blood flow constant. The very same mechanism applies to the kidney. Here it is the afferent arteriole that serves as a regulating valve to keep renal blood flow constant. However, the additional aspect of this regulation for the kidney is that with this mechanism Pgc and hence GFR are also maintained constant. This is just a consequence of the simple hydrodynamics of this system. Thus the significant changes in MAP in the renal artery can in theory be exactly compensated by the action of the afferent arteriolar valve, leaving all of the flow and pressures downstream of the valve unchanged.
Problems in autoregulation
In reality, autoregulation operates over a range of pressure changes and is not entirely “perfect”. Over a fairly wide range of MAP values (generally 75 to 150mm Hg in the human), RBF, Pgc, and GFR all remain fairly constant. However, there is some residual error in the autoregulatory mechanism, resulting in an upward creep of all three regulated variables as MAP increases. Outside the range of regulation, these variables do change rather dramatically. In particular, note how Pgc rises rapidly when MAP exceeds its autoregulatory range. This situation, such as occurs in malignant hypertension, can have grave consequences for the integrity of the delicate glomerular capillaries.
Response of the kidneys to severe hypovolemia
The autoregulatory mechanisms operate constantly during our normal daily lives, and they are intrinsic to the kidneys. However, we also have a built-in emergency response of the renal system in the rare event that our ECF volume decreases significantly, posing a threat to the function of the circulatory system. One of the vital circulatory responses to hypovolemia is to increase the resistance of the peripheral circulation, thus effectively shunting the remaining cardiac output to the organs essential for short term survival, namely the heart, brain, and lungs. In this scheme the kidneys are called upon to make their own blood flow reduction; this is especially important since the RBF is usually such a high proportion of the cardiac output. On the other hand, it is also important to viability that the kidneys not shut down markedly, but rather continue to process the plasma at a level as close to normal as possible. This is because both the primary pathological event (e.g. K+ release from tissues in muscle trauma or burns) and the recovery phase (e.g. drinking lots of pure water after severe dehydration) can involve threats to ECF homeostasis. However, complete filtration shutdown could easily occur if the volume loss leads to hypotension and a MAP drop below the autoregulatory range. Thus the kidneys have an alternative mechanism that preserves GFR at a reasonable level while also decreasing RBF.